• 00:15 1.
    index 1
  • 02:46 2.
    METTL3 mRNA was higher in gastric cancer
  • 00:53 3.
    Knockdown METTL3 inhibited the tumor proliferation
  • 00:01 4.
    Knockdown METTL3 inhibited the tumor proliferation
  • 00:19 5.
    Knockdown METTL3 inhibited the tumor proliferation
  • 01:33 6.
    Knockdown METTL3 inhibited the tumor proliferation
  • 00:30 7.
    Knockdown METTL3 inhibited the tumor proliferation
  • 03:01 8.
    Knockdown METTL3 inhibited the tumor proliferation
  • 10:44 9.
    METTL3 might have m6A-independent oncogenic functions
  • 03:07 10.
    METTL3 might have m6A-independent oncogenic functions
  • 03:32 11.
    METTL3 might have m6A-independent oncogenic functions
  • 01:43 12.
    METTL3 mainly located in cytoplasm in GC cells
  • 01:36 13.
    Cytoplasmic METTL3 enables its oncogenic activity
  • 00:01 14.
    Cytoplasmic METTL3 plays a role in translation initiation
  • 00:02 15.
    Cytoplasmic METTL3 enables its oncogenic activity
  • 02:07 16.
    Cytoplasmic METTL3 plays a role in translation initiation
  • 05:35 17.
    METTL3 regulated the translation of transcripts without m6A modification
  • 00:02 18.
    METTL3 regulated the translation of transcripts without m6A modification
  • 00:02 19.
    METTL3 regulated the translation of transcripts without m6A modification
  • 00:22 20.
    METTL3 regulated the translation of transcripts without m6A modification
  • 04:20 21.
    METTL3 promotes mRNA translation in an m6Aindependent manner
  • 05:51 22.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 00:06 23.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 00:01 24.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 01:48 25.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 03:10 26.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 03:06 27.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 01:01 28.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 02:25 29.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:59 30.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:01 31.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:16 32.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:36 33.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:44 34.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 01:22 35.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 01:41 36.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:55 37.
    Slide 32
  • 00:00 38.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 39.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 40.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 41.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 42.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:01 43.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:00 44.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:01 45.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:33 46.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 00:00 47.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:00 48.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:00 49.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:00 50.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:00 51.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 52.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 53.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 54.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 55.
    Slide 32
  • 00:00 56.
    Slide 33
  • 03:11 57.
    Slide 32
  • 00:00 58.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 59.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 60.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 61.
    Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
  • 00:00 62.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:00 63.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:00 64.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:00 65.
    METTL3–PABPC1 complex activates epigenetic regulator translation
  • 00:00 66.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 00:00 67.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 00:00 68.
    METTL3 interacts with PABPC1 to regulate RNA translation
  • 00:00 69.
    METTL3 promotes mRNA translation in an m6Aindependent manner
  • 00:00 70.
    METTL3 regulated the translation of transcripts without m6A modification
  • 00:00 71.
    METTL3 regulated the translation of transcripts without m6A modification
  • 00:00 72.
    Cytoplasmic METTL3 plays a role in translation initiation
  • 00:00 73.
    Cytoplasmic METTL3 enables its oncogenic activity
  • 00:01 74.
    METTL3 mainly located in cytoplasm in GC cells
  • 02:47 75.
    Cytoplasmic METTL3 enables its oncogenic activity
  • Index
  • Notes
  • Comment
  • Fullscreen
20221206 lab meeting_家銘
Duration: 1:13:45, Browse: 74, Last Updated: 2022-12-05
Attachment(s):
    Prev Next
    • 00:15 1.
      index 1
    • 02:46 2.
      METTL3 mRNA was higher in gastric cancer
    • 00:53 3.
      Knockdown METTL3 inhibited the tumor proliferation
    • 00:01 4.
      Knockdown METTL3 inhibited the tumor proliferation
    • 00:19 5.
      Knockdown METTL3 inhibited the tumor proliferation
    • 01:33 6.
      Knockdown METTL3 inhibited the tumor proliferation
    • 00:30 7.
      Knockdown METTL3 inhibited the tumor proliferation
    • 03:01 8.
      Knockdown METTL3 inhibited the tumor proliferation
    • 10:44 9.
      METTL3 might have m6A-independent oncogenic functions
    • 03:07 10.
      METTL3 might have m6A-independent oncogenic functions
    • 03:32 11.
      METTL3 might have m6A-independent oncogenic functions
    • 01:43 12.
      METTL3 mainly located in cytoplasm in GC cells
    • 01:36 13.
      Cytoplasmic METTL3 enables its oncogenic activity
    • 00:01 14.
      Cytoplasmic METTL3 plays a role in translation initiation
    • 00:02 15.
      Cytoplasmic METTL3 enables its oncogenic activity
    • 02:07 16.
      Cytoplasmic METTL3 plays a role in translation initiation
    • 05:35 17.
      METTL3 regulated the translation of transcripts without m6A modification
    • 00:02 18.
      METTL3 regulated the translation of transcripts without m6A modification
    • 00:02 19.
      METTL3 regulated the translation of transcripts without m6A modification
    • 00:22 20.
      METTL3 regulated the translation of transcripts without m6A modification
    • 04:20 21.
      METTL3 promotes mRNA translation in an m6Aindependent manner
    • 05:51 22.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 00:06 23.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 00:01 24.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 01:48 25.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 03:10 26.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 03:06 27.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 01:01 28.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 02:25 29.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:59 30.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:01 31.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:16 32.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:36 33.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:44 34.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 01:22 35.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 01:41 36.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:55 37.
      Slide 32
    • 00:00 38.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 39.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 40.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 41.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 42.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:01 43.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:00 44.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:01 45.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:33 46.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 00:00 47.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:00 48.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:00 49.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:00 50.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:00 51.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 52.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 53.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 54.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 55.
      Slide 32
    • 00:00 56.
      Slide 33
    • 03:11 57.
      Slide 32
    • 00:00 58.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 59.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 60.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 61.
      Cytoplasmic METTL3 predicts a poor outcome in patients with GC or PC
    • 00:00 62.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:00 63.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:00 64.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:00 65.
      METTL3–PABPC1 complex activates epigenetic regulator translation
    • 00:00 66.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 00:00 67.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 00:00 68.
      METTL3 interacts with PABPC1 to regulate RNA translation
    • 00:00 69.
      METTL3 promotes mRNA translation in an m6Aindependent manner
    • 00:00 70.
      METTL3 regulated the translation of transcripts without m6A modification
    • 00:00 71.
      METTL3 regulated the translation of transcripts without m6A modification
    • 00:00 72.
      Cytoplasmic METTL3 plays a role in translation initiation
    • 00:00 73.
      Cytoplasmic METTL3 enables its oncogenic activity
    • 00:01 74.
      METTL3 mainly located in cytoplasm in GC cells
    • 02:47 75.
      Cytoplasmic METTL3 enables its oncogenic activity
    Location
    1. Media Center
    2. ...
    3. 2022
    Folder name
    2022
    Author
    林俐妤
    Branch
    賴亮全教授
    Created
    2022-12-05 11:14:10
    Last Updated
    2022-12-05 11:43:24
    Browse
    74
    Duration
    1:13:45

    臺北市仁愛路一段1號10樓1009室

    R1009 10F No1 Sec1 Ren-Ai Rd, Taipei 100233, Taiwan.

    E-mail: llai@ntu.edu.tw

    Tel: 886-2-2312-3456 # 288241

    Lab: 886-2-2393-8235